Directory · AU
Biotechnology in Australia
A register of firms and the professionals working at them in the Biotechnology sector based in Australia. Browse the public index, then filter or export on Kipplo.
Companies
116 on file
Protagonist Therapeutics
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs. Our platform enables us to discover peptides in a de novo fashion with the desired degree of potency, specificity and selectivity, and also engineer oral stability with specific peptidomimetic and chemical modifications.
51 to 200 staff
Agilex Biolabs Pty Ltd
Agilex Biolabs is Australia’s regulated bioanalytical and toxicology CRO offering both large and small molecule development with extensive cell & gene therapy capabilities and expertise. For over 25 years, we are recognised for our scale and proven track record for large and small molecule bioanalysis, including quality method development, method validation and sample analysis services. Our world-class immunoassay and immunobiology laboratories feature state-of-the-art equipment, including Gyrolab xPlore, MSD Quickplex 120, Luminex Magpix, BD FACSymphony A3 flow cytometer and the digital droplet quantitative real-time analysis for RNA, siRNA, and miRNA clinical trials, including vaccines and gene therapy trials. Furthermore, Agilex Biolabs has ISO/IEC17025 accreditation and OECD GLP recognition with NATA to ensure the highest quality standards are met for seamless end to end testing for pre-clinical to clinical analysis. Agilex Biolabs also offers a range of toxicology services to support preclinical through to early/late-phase clinical programs through TetraQ, an established GLP facility located in Brisbane, Australia. These services include exploratory toxicology and pharmacokinetics studies, and GLP toxicology services. We have expertise with all types of molecules, laboratory species, routes of administration, and non-clinical studies. Being at the forefront of regulated bioanalysis, Agilex has invested heavily in world-class customised equipment and is continuing to push the boundaries by investment in new infrastructure, and identification of new ways to automate and streamline data acquisition through to reporting to support scientific and regulatory excellence and maintain its position as the leading bioanalytical laboratory within the Asia Pacific Region.
51 to 200 staff
Marinova Pty Ltd
Marinova is an Australian biotechnology company dedicated to the development and production of high purity seaweed extracts for the betterment of human health. We specialise in the research, development and manufacture of fucoidan compounds – highly bioactive polysaccharides derived from select species of brown seaweed. As the global leader in fucoidan science, Marinova is the supplier of choice to world-renowned research institutions. Our reputation is built on the unrivalled quality and efficacy of our bioactive fucoidan extracts and two decades of rigorous scientific investigation. Marinova’s global research and development program welcomes collaborators that share our mindset for scientific innovation. Our highly characterised fucoidan fractions are well-suited to medical device applications and pharmaceutical research. Marinova is also home to the range of unique Maritech® organic fucoidan extracts - high purity fucoidans developed specifically for nutritional, cosmetic and animal health applications. Marinova – Pure Source, Pure Science.
11 to 50 staff
Optalert
Optalert developed the world’s leading algorithm to quantify the deterioration in cognitive brain function due to drowsiness and created the Johns Drowsiness Scale (JDS) which remains the only scientifically proven, objective measurement of drowsiness. The JDS is used worldwide in research for accurately quantifying drowsiness levels, and in Optalert’s early-warning drowsiness detection systems to protect thousands of lives and valuable company assets across multiple industries. Our clients include BHP Billiton, Vale and NASA. Our research partners include the Harvard Medical School, Monash University, and the University of Queensland. Optalert is a Medical Technology company pioneering the use of Blepharometry (the measurement of blinks) to measure drowsiness. Optalert discovered a key biomarker for drowsiness, the connection between brain function and eyelid movement. Optalert is now turning its extensive expertise in Blepharometry and Artificial Intelligence to identify the biomarkers for other degradations to neurological brain function in conditions such as Epilepsy (due to onset of seizures), ADHD, Parkinson’s, Alzheimer’s, TBI, concussion and motor neuron disease.
11 to 50 staff
Pacific Bio
At Pacific Bio, we are pioneering a world-first macroalgal circular economy that delivers scalable, cost-advantaged solutions across water, energy, agriculture, and industry. Our RegenAqua platform is a breakthrough in nature-based wastewater treatment—cleaning water while producing reliable algae biomass. That biomass fuels our entire ecosystem: PlantJuice & Bio Granules – natural biostimulants and soil enhancers helping farmers boost yields sustainably. Pacific Bio Energy – transforming algae into next-generation biofuels, including biocrude, bioethanol, and biomethane, unlocking pathways to SAF and renewable energy at scale. Data Centre Solutions – addressing the water-energy nexus by providing innovative cooling and sustainability pathways for global digital infrastructure. From wastewater to energy and agriculture, our integrated model captures value at every stage—turning environmental challenges into commercial opportunities while delivering measurable impact for people and planet. We are proud to partner with industry, utilities, governments, and research leaders to scale a truly circular solution—cleaner water, sustainable energy, healthier soils, and stronger communities.
11 to 50 staff
Inoviq Ltd Asx Iiq
INOVIQ Ltd (ASX:IIQ) is a biotechnology company developing next-generation diagnostics and therapeutics for cancer. INOVIQ has commercialised its fast, efficient and scalable EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test as an adjunct test for bladder cancer. The company is advancing clinical-stage diagnostics for detection and monitoring of ovarian and breast cancers, and early-stage exosome therapeutics for solid tumours.
11 to 50 staff
Actinogen Medical
Actinogen Medical (ASX:ACW) is an ASX-listed biotechnology company developing a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. There is a strong association between persistent stress and the production of excess cortisol that leads to changes in the brain affecting memory, cognitive function, behaviour and neuropsychological symptoms. Actinogen’s lead compound, Xanamem, has been specifically designed to reduce production of intracellular cortisol - the stress hormone - through the inhibition of the 11β-HSD1 enzyme in the brain. The 11β-HSD1 enzyme is highly concentrated in the areas of the brain associated with cognitive impairment in early Alzheimer’s Disease (AD) and Depression, and other neurological and psychiatric diseases. Because of its ability to reach these areas of the brain and inhibit this enzyme, Xanamem is very different from other treatments for cognitive impairment. Actinogen has studied 11β-HSD1 inhibition by Xanamem in more than 300 volunteers and patients, so far finding a statistically significant improvement in working memory and attention, compared with placebo, in healthy, older volunteers in two consecutive trials and clinically significant improvements in patients with biomarker-positive mild AD. Previously, high levels of target engagement in the brain with doses as low as 5 mg daily have been demonstrated in a human PET imaging study. The Company is rapidly moving forward into its upcoming double-blind, randomized, placebo-controlled Phase 2 trials in cognitive impairment in Alzheimer’s Disease and Depression to further confirm and characterize Xanamem’s therapeutic potential. The XanaMIA Phase 2b AD trial comprises 330 patients with mild Alzheimer’s Disease and the XanaCIDD Phase 2a trial will total 160 patients with depression.
11 to 50 staff
Hiro - Harvest Integrated Research Organization - Anz Formerly Pharmasols
HiRO ANZ (formerly PharmaSols) is the longest established, best connected, privately-owned Clinical Research Organisation (CRO) in the Pacific region. For over 25 years, we have successfully supported patient needs and delivered outstanding results for global Pharma, Biotechs and CROs across hundreds of studies. Our team has international experience with large pharmaceutical, medical device and biotech organisations, with expertise across a wide variety of therapeutic areas. Inspired by their contribution to improving health and wellbeing, our passionate team works with you to support and facilitate your clinical trials, delivering participant recruitment and retention targets, and quality data outcomes. Our strong, trusted relationships with partners, clients, key opinion leaders, site staff, and investigators means we lead the way in: Start-to-finish project management and clinical operations Site selection and participant recruitment Ethics committee and regulatory submissions Data management and biostatistics Quality assurance Local sponsorship and third-party vendor management Commercial regulatory consultancy Flexible, responsive and innovative, we are based in Australia and New Zealand – the best place in the world to conduct clinical trials. Talk to us about your next study.
51 to 200 staff
Immvirx
ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect. The company is developing a bio-selected RNA virus to induce tumour inflammation and achieve immune cell infiltration via the RIG-I pathway. The targets for this approach are Ovarian, Head & Neck and those indications which present with liver metastases such as Colorectal, Hepatocellular carcinoma and Pancreatic cancer. The approach includes combination therapy with Immune Checkpoint Inhibitors and CAR-T agents using bio-selected RNA virus. The company founders, Malcolm McColl and Prof. Darren Shafren, were Managing Director and CSO of Viralytics, an ASX listed oncolytic virus company acquired in June 2018 by Merck and Co. Inc. for A$502 million. The ImmVirX team includes key management and researchers from Viralytics and is based at the former Viralytics laboratory facilities in Newcastle Australia.
11 to 50 staff
Kiora Pharmaceuticals, Inc
Kiora Pharmaceuticals, Inc.(Kiora) is a clinical stage biotech company focusing on novel therapeutics for the treatment of retinal diseases. Publicly traded on the NASDAQ under KPRX, our mission is to help patients improve and/or restore vision.
11 to 50 staff
Mx3 Diagnostics
THE POWER OF A LAB IN THE PALM OF YOUR HAND MX3 is changing what's possible for health diagnostics. This revolutionary platform is the first simple, reliable way to measure and track salivary and sweat biomarkers anytime, anywhere. HYDRATION TRACKING SOLUTIONS In a variety of markets – from health care to sports, military to mining – health and safety are vital to employee wellbeing and productivity. MX3’s emerging technology in health care provides point-of-care, immediate diagnostic solutions to one of the key markers of health and safety: hydration status. MX3 Diagnostics’ revolutionary products offer the key to tracking and understanding hydration, offering point-of-care testing solutions to many common employee, workplace, and performance-related health concerns. https://linktr.ee/mx3diagnostics
11 to 50 staff
Proagni
About ProAgni ProAgni is an agricultural bioscience company dedicated to transforming animal agriculture through innovative and sustainable solutions. With a focus on reducing the environmental impact of food production, we develop and commercialize groundbreaking animal nutrition products that enhance farm profitability while addressing global challenges such as antibiotic use and enteric methane emissions. Our Mission At ProAgni, our mission is to drive sustainability in agriculture by discovering and delivering products that not only improve the performance and health of livestock but also significantly reduce methane emissions and antibiotic use. We believe in creating solutions that benefit both farmers and the planet. Our Innovations Our flagship product line, ProTect, offers feed supplements for cattle and sheep that- Increase animal performance, boosting farm profitability - Decrease methane emissions, contributing to climate change mitigation - Contain no antibiotics, helping combat antimicrobial resistance
1 to 10 staff
Dna Solutions
DNA Solutions have been assisting individuals around the globe with DNA Paternity & relationship analysis & were the first pioneering company offering DNA home kits to test for paternity and introduced these back in the 90’s. Many of our technical staff and management are ex-police and ex-military DNA testing forensic scientists, further enhancing the quality and range of our DNA tests. Processing occurs in our own DNA laboratory, our lab is capable of DNA ancestry testing, paternity testing, relationship tests, DNA banking and preservation, where we additionally carry out extensive research and development. We have offices and laboratories worldwide & serve thousands of individuals and organizations globally
51 to 200 staff
Vow
Vow is a cultured meat company, founded and operated in Sydney, Australia. We’re a multidisciplinary team of scientists, technologists and designers, all working together to make sustainable food both irresistible and available to billions of people.
51 to 200 staff
Alloplex Biotherapeutics Inc
Alloplex Biotherapeutics is dedicated to exploring the higher order combinatorial space of immunomodulators to develop an effective anti-tumor vaccine. This approach is applicable to all tumor types and is particularly suited to combinations with checkpoint inhibitors. Alloplex is a private company and currently supported by angel investment
1 to 10 staff
Number 8 Bio
Number 8 bio is developing innovative solutions capable of reducing ruminant methane emissions, saving money for our farmers, and saving our climate.
1 to 10 staff
Biode Pty Ltd
We are a team of BIOMETRIC EXPERTS, leading the industry through software innovations to protect people and physical assets within Government and Commercial organisations. BIODE was founded on decades of biometric experience, and our specialised solutions continue to protect many of Australia's most trusted companies. We've come a long way over the past 20 years, but we're just getting started!
11 to 50 staff
Apac Scientific Pty Ltd
APAC Scientific offers high quality product solutions to scientists and medical professionals. Based in Australia, we combine expert knowledge of global brands with exceptional local service. We collaborate with innovative medical, clinical and scientific businesses to widen distribution and increase sales in the Asia Pacific region. Together with our partners, we implement comprehensive sales, marketing and support strategies that provide beneficial outcomes for our customers. Our goal is to represent the best quality products that meet the research and educational needs of our customers, and in turn align with our customers’ goals by providing informed advice and technical support at a local level.
1 to 10 staff
Astral Scientific Pty Ltd
Founded in 1987, Astral Scientific Pty Ltd has grown to be a key supplier to the Life Science, Diagnostic and Pharmaceutical markets. Our extensive offering of innovative products has been carefully selected to provide you and your laboratory team a value and quality proposition that is unequalled. Our growth and success have been the result of our dedication to quality, service and value to our customers - the people who ultimately use our products in their laboratories. Your 100% satisfaction is now, as it has been from the beginning, our primary concern.
11 to 50 staff
Biomecentric
Australia’s first 'BiomeCentric' contract manufacturer. We harness innovative manufacturing solutions and microbiome-centric technologies to bring your beauty, cosmetic and healthcare products to life. We’re proud to be able to share our expertise and innovation to deliver purpose-filled, system-driven products that you can take to market with pride. BiomeCentric develop products that challenge and beat the status quo. We’re passionate about helping our customers harness the value of microbiome-centric and organic ingredients through the delivery of innovative formulas to produce power-packed cosmetics, skincare, body care and healthcare products that make a difference. We want to support brands to broaden their thinking and unleash their potential to create life-enhancing products and challenges how products are applied and consumed. We strive to make a living difference to the ecosystems of our bodies and the world around us, creating a sustainable link and maintaining the health between these interconnected systems. BiomeCentric cultivates microbiome innovation through our state-of-the-art facility, which includes advanced bioprocessing and contract manufacturing capabilities. Our primary objectives encompass successfully commercialising novel biological active ingredients, as well as developing inventive product formulations and finished products that target both gut and skin microbiomes.
11 to 50 staff
Change Plastic For Good Ltd
Plastic is one of the best inventions on earth. We wear it, drive in it, use endless products made with it and nothing can replace it. When we are done using it, it is a stubborn mess to manage. Our little butterfly logo represents a change in plastic for good and by giving a portion of profits to ocean cleanup programs, we help clean up the mess, past present and future.
11 to 50 staff
Ck Cell Technologies Pty Ltd
CK Cell Technologies develop innovative stem cell technologies for the treatment of human conditions using collaborative strategies involving clinicians and scientists under one umbrella. We are a R&D company developing the innovative science of stem cells into diagnostic and therapeutic modalities for osteoarthritis, various neurodegenerative diseases and skin repair.
1 to 10 staff
Drop Bio Health
Drop Bio Health develops tools that improve the analytical performance of at-home collected health tests by addressing the issues associated with sample degradation. Through improved analytical performance we broaden the range of tests that can be accurately conducted on at-home collected samples, creating more opportunities for at-home testing and expanding the reach and access to these services.
11 to 50 staff
Fungi Solutions
Fungi Solutions was created to transform waste into valuable resources and bespoke mycelium products. We are committed to growing a sustainable and circular future for Australian manufacturing that celebrates our rich natural resources and agricultural producers. We create beautiful natural alternatives to polystyrene and leather that are lightweight, durable, insulating and 100% home compostable.
1 to 10 staff
